A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
|Articles|August 17, 2021
Pharmacy Clinical Pearl of the Day: Comprehensive Metabolic Panel vs Complete Blood Count Labs
Author(s)Saro Arakelians, PharmD
Physicians may ask for either or both of comprehensive metabolic panel or complete blood count tests every 3 to 6 months, based on the conditions patients have.
Advertisement
Clinical Pearl of the Day: Comprehensive Metabolic Panel vs Complete Blood Count Labs
- Complete Blood Count (CBC): A CBC lab helps your health professional diagnose conditions such as infection, anemia, and several other disorders.
- Comprehensive Metabolic Panel (CMP-14): With eGFR is a group of 14 laboratory tests ordered to give information about the status of the liver, kidneys, and electrolyte and acid/base balance.
Explanation:
- CBC gives important information about the numbers and kinds of cells in the blood, especially red blood cells, white blood cells, and platelets.
CMP-14 tests give the status of blood sugar and blood proteins. Physicians may ask for one or both of these tests every 3 to 6 months, based on the disease conditions the patient may have.
Reference
Advertisement
Related to this article
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
October’s hematology coverage highlighted first-line pirtobrutinib, questions about myeloma treatment duration and early intervention, and pharmacists’ roles in medication safety and access.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
2
Diabetes Awareness Month Opens Amid New T1D, T2D Approvals
3
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5